IVC filter retrieval: a multicenter proposal of two score systems to predict application of complex technique and procedural outcome

Giurazza, Francesco; Contegiacomo, Andrea; Calandri, Marco; Mosconi, Cristina; Modestino, Francesco; Corvino, Fabio; Scrofani, Anna Rita; Marra, Paolo; Coniglio, Giovanni; Failla, G.; Lucarelli, Nicola Maria; Femia, Marco; Semeraro, Vittorio; Ierardi, Anna Maria

doi:10.1007/s11547-021-01356-6

Cited by 16 publications

(9 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, a thorough knowledge of the imaging methods available and the interactions between the clinician and the radiologist are essential for making the correct choices for individual patients, for better management, and to improve treatment and survival [ 60 , 61 , 62 , 63 ].…”

Section: Discussionmentioning

confidence: 99%

Imaging Assessment of Interval Metastasis from Melanoma

Simonetti

Trovato²,

Granata

et al. 2022

JPM

View full text Add to dashboard Cite

Interval metastasis is a particular metastatic category of metastatic localizations in the lymph nodes in patients with melanoma. Interval nodes are generally located at nonregional lymphatic stations placed along the pathway of the spread of melanoma, such as the epitrochlear lymph node station, the popliteal fossa, and the retroareolar station. Imaging techniques for evaluation of patients with interval metastasis from melanoma diseases include ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), lymphoscintigraphy (LS), and positron emission tomography (PET). A literature review was conducted through a methodical search on the Pubmed and Embase databases. The evaluation of lymph node metastases represents a critical phase in the staging and follow-up of melanoma patients. Therefore, a thorough knowledge of the imaging methods available and the interactions between the clinician and the radiologist are essential for making the correct choice for individual patients, for a better management, and to improve treatment and survival.

show abstract

Section: Discussionmentioning

confidence: 99%

Imaging Assessment of Interval Metastasis from Melanoma

Simonetti

Trovato²,

Granata

et al. 2022

JPM

View full text Add to dashboard Cite

show abstract

“…In this context, proper management should prevent progression to invasive cancer and should minimize the need for lifelong screening and related costs [179]. Much research has reported an accuracy in recognizing the sub-type of PCN, between 40% and 95% for MRI/MRCP and between 40% and 81% for CT [180][181][182][183][184][185][186][187][188][189], and a CT detection rate of 2.1-2.6% [189,190] and MRI/MRCP detection rate of 13.5-45% [191,192]. However, the diagnostic accuracy is low, using either single or combined imaging tools for differentiating small PCN from non-neoplastic or non-epithelial cysts, or for connection to the ductal system [180][181][182][183][184][185][186][187][188][189][190][191][192].…”

Section: Pancreatic Cystic Neoplasm Diagnostic Managementmentioning

confidence: 99%

Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence

Granata

Fusco

Setola

et al. 2023

Cancers

View full text Add to dashboard Cite

Pancreatic cancer (PC) is one of the deadliest cancers, and it is responsible for a number of deaths almost equal to its incidence. The high mortality rate is correlated with several explanations; the main one is the late disease stage at which the majority of patients are diagnosed. Since surgical resection has been recognised as the only curative treatment, a PC diagnosis at the initial stage is believed the main tool to improve survival. Therefore, patient stratification according to familial and genetic risk and the creation of screening protocol by using minimally invasive diagnostic tools would be appropriate. Pancreatic cystic neoplasms (PCNs) are subsets of lesions which deserve special management to avoid overtreatment. The current PC screening programs are based on the annual employment of magnetic resonance imaging with cholangiopancreatography sequences (MR/MRCP) and/or endoscopic ultrasonography (EUS). For patients unfit for MRI, computed tomography (CT) could be proposed, although CT results in lower detection rates, compared to MRI, for small lesions. The actual major limit is the incapacity to detect and characterize the pancreatic intraepithelial neoplasia (PanIN) by EUS and MR/MRCP. The possibility of utilizing artificial intelligence models to evaluate higher-risk patients could favour the diagnosis of these entities, although more data are needed to support the real utility of these applications in the field of screening. For these motives, it would be appropriate to realize screening programs in research settings.

show abstract

“…Different diagnostic techniques may be utilized, alone or as a multimodality approach [ 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 ]. Computed tomography (CT) and magnetic resonance imaging (MRI) are the main imaging tools employed during the pre-procedural phase in order to evaluate liver lesions [ 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 ] and in the surveillance phase to assess the efficacy and the safety [ 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 ...…”

Section: Non Anatomic Liver Resectionmentioning

confidence: 99%

Imaging Features of Main Hepatic Resections: The Radiologist Challenging

Cutolo

Fusco

Simonetti

et al. 2023

JPM

View full text Add to dashboard Cite

Liver resection is still the most effective treatment of primary liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), and of metastatic disease, such as colorectal liver metastases. The type of liver resection (anatomic versus non anatomic resection) depends on different features, mainly on the type of malignancy (primary liver neoplasm versus metastatic lesion), size of tumor, its relation with blood and biliary vessels, and the volume of future liver remnant (FLT). Imaging plays a critical role in postoperative assessment, offering the possibility to recognize normal postoperative findings and potential complications. Ultrasonography (US) is the first-line diagnostic tool to use in post-surgical phase. However, computed tomography (CT), due to its comprehensive assessment, allows for a more accurate evaluation and more normal findings than the possible postoperative complications. Magnetic resonance imaging (MRI) with cholangiopancreatography (MRCP) and/or hepatospecific contrast agents remains the best tool for bile duct injuries diagnosis and for ischemic cholangitis evaluation. Consequently, radiologists should be familiar with the surgical approaches for a better comprehension of normal postoperative findings and of postoperative complications.

show abstract

IVC filter retrieval: a multicenter proposal of two score systems to predict application of complex technique and procedural outcome

Cited by 16 publications

References 18 publications

Imaging Assessment of Interval Metastasis from Melanoma

Imaging Assessment of Interval Metastasis from Melanoma

Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence

Imaging Features of Main Hepatic Resections: The Radiologist Challenging

Contact Info

Product

Resources

About